AcouSort AB (publ) (ACOU.ST)
SEK 11.5
(-0.86%)
SEK 11.5
(-0.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -23.98 Million SEK | 29.4% |
| 2022 | -33.97 Million SEK | -7.78% |
| 2021 | -31.52 Million SEK | -288.05% |
| 2020 | -8.12 Million SEK | -59.18% |
| 2019 | -5.1 Million SEK | 67.15% |
| 2018 | -15.53 Million SEK | -536.12% |
| 2017 | -2.44 Million SEK | -429.72% |
| 2016 | -461 Thousand SEK | -384.51% |
| 2015 | -95.14 Thousand SEK | 85.51% |
| 2014 | -656.5 Thousand SEK | -195.14% |
| 2013 | -222.43 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -20.37 Million SEK | 15.05% |
| 2024 Q2 | -16.68 Million SEK | 18.13% |
| 2023 Q2 | -11.88 Million SEK | 35.31% |
| 2023 FY | -23.98 Million SEK | 29.4% |
| 2023 Q4 | -23.98 Million SEK | -266.2% |
| 2023 Q1 | -18.37 Million SEK | 45.91% |
| 2023 Q3 | -6.55 Million SEK | 44.91% |
| 2022 Q2 | -24.09 Million SEK | 15.59% |
| 2022 FY | -33.97 Million SEK | -7.78% |
| 2022 Q4 | -33.97 Million SEK | -78.65% |
| 2022 Q1 | -28.53 Million SEK | 9.46% |
| 2022 Q3 | -19.01 Million SEK | 21.06% |
| 2021 Q4 | -31.52 Million SEK | -1786.36% |
| 2021 Q2 | -4.59 Million SEK | 7.92% |
| 2021 Q1 | -4.98 Million SEK | 38.63% |
| 2021 Q3 | -1.67 Million SEK | 63.59% |
| 2021 FY | -31.52 Million SEK | -288.05% |
| 2020 Q1 | -3.03 Million SEK | 40.51% |
| 2020 Q3 | -10.87 Million SEK | 21.09% |
| 2020 FY | -8.12 Million SEK | -59.18% |
| 2020 Q4 | -8.12 Million SEK | 25.3% |
| 2020 Q2 | -13.78 Million SEK | -353.92% |
| 2019 Q1 | -13.45 Million SEK | 13.4% |
| 2019 Q3 | -7.77 Million SEK | 24.86% |
| 2019 Q4 | -5.1 Million SEK | 34.32% |
| 2019 FY | -5.1 Million SEK | 67.15% |
| 2019 Q2 | -10.34 Million SEK | 23.13% |
| 2018 Q3 | -18.22 Million SEK | 10.73% |
| 2018 FY | -15.53 Million SEK | -536.12% |
| 2018 Q4 | -15.53 Million SEK | 14.77% |
| 2018 Q2 | -20.41 Million SEK | -1675.48% |
| 2018 Q1 | -1.15 Million SEK | 52.91% |
| 2017 Q3 | -4.93 Million SEK | 30.87% |
| 2017 Q4 | -2.44 Million SEK | 50.55% |
| 2017 FY | -2.44 Million SEK | -429.72% |
| 2017 Q2 | -7.14 Million SEK | 21.29% |
| 2017 Q1 | -9.07 Million SEK | -1868.55% |
| 2016 FY | -461 Thousand SEK | -384.51% |
| 2016 Q4 | -461 Thousand SEK | 22.26% |
| 2016 Q3 | -593 Thousand SEK | 0.0% |
| 2015 Q4 | -95.14 Thousand SEK | 0.0% |
| 2015 FY | -95.14 Thousand SEK | 85.51% |
| 2014 FY | -656.5 Thousand SEK | -195.14% |
| 2013 FY | -222.43 Thousand SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | -50.02 Million SEK | 52.048% |
| Ziccum AB (publ) | -2.13 Million SEK | -1022.415% |
| Modus Therapeutics Holding AB (publ) | -19.06 Million SEK | -25.845% |
| BioArctic AB (publ) | -606.58 Million SEK | 96.046% |
| Sprint Bioscience AB (publ) | -49.93 Million SEK | 51.965% |
| Mendus AB (publ) | -96.29 Million SEK | 75.091% |
| Genovis AB (publ.) | -43.94 Million SEK | 45.413% |
| Intervacc AB (publ) | -88.16 Million SEK | 72.793% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 20.51 Million SEK | 216.948% |
| Active Biotech AB (publ) | -33.2 Million SEK | 27.753% |
| Magle Chemoswed Holding AB (publ) | 53.22 Million SEK | 145.067% |
| Bio-Works Technologies AB (publ) | -39.38 Million SEK | 39.094% |
| Aptahem AB (publ) | 2.9 Million SEK | 924.646% |
| Vicore Pharma Holding AB (publ) | -333.62 Million SEK | 92.81% |
| Kancera AB (publ) | -45.69 Million SEK | 47.505% |
| Infant Bacterial Therapeutics AB (publ) | -329.06 Million SEK | 92.711% |
| Fluicell AB (publ) | -2.76 Million SEK | -768.114% |
| Saniona AB (publ) | 40.44 Million SEK | 159.302% |
| Lipigon Pharmaceuticals AB (publ) | -31.92 Million SEK | 24.872% |
| Biovica International AB (publ) | -58.73 Million SEK | 59.164% |
| Spago Nanomedical AB (publ) | -45.21 Million SEK | 46.954% |
| Xintela AB (publ) | -7.8 Million SEK | -207.158% |
| Abliva AB (publ) | -57.24 Million SEK | 58.096% |
| Egetis Therapeutics AB (publ) | -194.7 Million SEK | 87.681% |
| Karolinska Development AB (publ) | -82.2 Million SEK | 70.821% |
| OncoZenge AB (publ) | -12.62 Million SEK | -89.958% |
| Amniotics AB (publ) | -5.63 Million SEK | -325.888% |
| 2cureX AB (publ) | -13.4 Million SEK | -78.96% |
| CombiGene AB (publ) | -101.44 Million SEK | 76.354% |
| Asarina Pharma AB (publ) | -2.16 Million SEK | -1009.949% |
| Calliditas Therapeutics AB (publ) | 5.4 Million SEK | 544.185% |
| Camurus AB (publ) | -1.16 Billion SEK | 97.942% |
| Corline Biomedical AB | -17.01 Million SEK | -40.995% |
| IRLAB Therapeutics AB (publ) | -83.74 Million SEK | 71.358% |
| Isofol Medical AB (publ) | -138.14 Million SEK | 82.637% |
| I-Tech AB | -83.26 Million SEK | 71.192% |
| Hansa Biopharma AB (publ) | 134.7 Million SEK | 117.806% |
| Cyxone AB (publ) | -16.67 Million SEK | -43.887% |
| ExpreS2ion Biotech Holding AB (publ) | -55.88 Million SEK | 57.08% |
| Biosergen AB | -1.88 Million SEK | -1173.818% |
| Cantargia AB (publ) | -139.74 Million SEK | 82.836% |
| NextCell Pharma AB | -46.79 Million SEK | 48.738% |
| Xspray Pharma AB (publ) | -129.49 Million SEK | 81.477% |
| Elicera Therapeutics AB (publ) | -29.38 Million SEK | 18.368% |
| Nanologica AB (publ) | -9.38 Million SEK | -155.496% |
| SynAct Pharma AB | -61.75 Million SEK | 61.161% |
| Annexin Pharmaceuticals AB (publ) | -21.41 Million SEK | -12.006% |
| Stayble Therapeutics AB (publ) | -13.22 Million SEK | -81.311% |
| LIDDS AB (publ) | -13.51 Million SEK | -77.516% |
| Lipum AB (publ) | -8.46 Million SEK | -183.355% |
| BioInvent International AB (publ) | -236.3 Million SEK | 89.85% |
| Alzinova AB (publ) | -21.22 Million SEK | -13.003% |
| Oncopeptides AB (publ) | -66.92 Million SEK | 64.157% |
| Pila Pharma AB (publ) | -5.18 Million SEK | -362.968% |
| Guard Therapeutics International AB (publ) | -83.74 Million SEK | 71.357% |
| Scandinavian ChemoTech AB (publ) | -923 Thousand SEK | -2498.7% |
| Simris Alg AB (publ) | 85.07 Million SEK | 128.194% |
| Diamyd Medical AB (publ) | -82.08 Million SEK | 70.779% |
| Xbrane Biopharma AB (publ) | 166.07 Million SEK | 114.443% |
| Ascelia Pharma AB (publ) | -20.79 Million SEK | -15.356% |
| Diagonal Bio AB (publ) | -2.97 Million SEK | -707.066% |